<?xml version="1.0" encoding="UTF-8" standalone="yes"?><EventTranscript id="5892620"><Name>Merck &amp; Co Inc at Goldman Sachs Healthcare CEOs Unscripted: A View from the Top Conference</Name><Company>Merck &amp; Co Inc</Company><Drugs><Drug>sitagliptin</Drug><Drug>pembrolizumab</Drug><Drug>boceprevir</Drug><Drug>temozolomide</Drug><Drug>suvorexant</Drug><Drug>docetaxel</Drug><Drug>ezetimibe + simvastatin</Drug><Drug>laropiprant + extended-release niacin (coronary artery disease/atherosclerosis), Merck &amp; Co</Drug><Drug>empagliflozin</Drug><Drug>sofosbuvir + ledipasvir (fixed-combination/oral, HCV/HBV), Gilead</Drug><Drug>ezetimibe</Drug><Drug>aprepitant</Drug><Drug>nivolumab</Drug><Drug>odanacatib</Drug></Drugs></EventTranscript>